FDA Rejects Savient's Gout Drug - New York Times

dBTechno

FDA Rejects Savient's Gout Drug New York Times Gout is a painful form of arthritis that appears to be on the increase, in part because of richer diets, obesity and the aging of society. ... Savient Plunges As FDA Holds Off On Drug ApprovalWall Street Journal FDA Refuses to Approve Savient Gout DrugTheStreet.com FDA Approves Colchicine for Acute Gout, Mediterranean FeverDocuticker Visit Bulgaria -FierceBiotech all 75 news articles »

bofa, Ford, Alcoa, Huron Consulting are big movers - The Associated Press

bofa, Ford, Alcoa, Huron Consulting are big movers The Associated Press Savient Pharmaceuticals Inc., down .79 at .80 The FDA rejected the drug developer's gout treatment, citing manufacturing problems and a need for ... and more »

PREVIEW-Marketing, not approval, a worry for Savient gout drug - Reuters

PREVIEW-Marketing, not approval, a worry for Savient gout drug Reuters O) potential gout drug, Krystexxa, is expected to have a smooth path to US regulatory approval, even though adverse events reported during trials may result ... and more »

US Small-Caps Rise, Boosted By Positive Economic Data - Wall Street Journal

US Small-Caps Rise, Boosted By Positive Economic Data Wall Street Journal The agency said there are "deficiencies with the chemistry, manufacturing and controls" portion of the application for Krystexxa, along with problems with ... and more »